Clinical Trial Update: Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease [Phase 1]

View source ↗

Summary

Phase 1 safety update on using Plerixafor to mobilize blood stem cells in patients with Sickle Cell Disease; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Plerixafor (Plerixafor)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Sickle Cell Disease | Phase 1 | Status: ACTIVE_NOT_RECRUITING